News & Updates

Show Multimedia Only
Single intranasal dose of live-attenuated vaccine confers broad protection against coronaviruses, including SARS-CoV-2
Single intranasal dose of live-attenuated vaccine confers broad protection against coronaviruses, including SARS-CoV-2
13 Feb 2026
Nivolumab-ipilimumab combo plus surgery improves survival in HCC
Nivolumab-ipilimumab combo plus surgery improves survival in HCC
11 Feb 2026 byStephen Padilla

Patients with potentially resectable hepatocellular carcinoma (HCC) may receive neoadjuvant nivolumab plus ipilimumab therapy, followed by surgery, to improve their survival, suggests a study.

Nivolumab-ipilimumab combo plus surgery improves survival in HCC
11 Feb 2026